Heterogeneity of determining disease severity, clinical course and outcomes in systemic sclerosis-associated interstitial lung disease: a systematic literature review
L Petelytska, F Bonomi, C Cannistrà, E Fiorentini… - RMD open, 2023 - rmdopen.bmj.com
Objective The course of systemic sclerosis-associated interstitial lung disease (SSc-ILD) is
highly variable and different from continuously progressive idiopathic pulmonary fibrosis …
highly variable and different from continuously progressive idiopathic pulmonary fibrosis …
Anti-Ro52 positivity is associated with progressive interstitial lung disease in systemic sclerosis—an exploratory study
V Hamberg, A Sohrabian, ER Volkmann… - Arthritis Research & …, 2023 - Springer
Background Interstitial lung disease (ILD) is the most common cause of death in patients
with systemic sclerosis (SSc). Prognostic biomarkers are needed to identify SSc-ILD patients …
with systemic sclerosis (SSc). Prognostic biomarkers are needed to identify SSc-ILD patients …
The 'whole landscape'of research on systemic sclerosis over the past 73 years
MD Zhang, WY Huang, JY Luo, RQ He, ZG Huang… - Autoimmunity …, 2024 - Elsevier
Objective This study aimed to analyse existing research on systemic sclerosis (SSc)
conducted over the past 73 years to develop an essential reference for a comprehensive …
conducted over the past 73 years to develop an essential reference for a comprehensive …
[HTML][HTML] Early detection of interstitial lung disease in rheumatic diseases: A joint statement from the Portuguese Pulmonology Society, the Portuguese Rheumatology …
A Morais, AC Duarte, MO Fernandes, A Borba… - Pulmonology, 2023 - Elsevier
Introduction Interstitial lung disease (ILD) contributes significantly to morbidity and mortality
in connective tissue disease (CTD). Early detection and accurate diagnosis are essential for …
in connective tissue disease (CTD). Early detection and accurate diagnosis are essential for …
The Value of Ultrasound for Detecting and Following Subclinical Interstitial Lung Disease in Systemic Sclerosis
M Gutierrez, C Bertolazzi, E Zozoaga-Velazquez… - Tomography, 2024 - mdpi.com
Background: Interstitial lung disease (ILD) is a complication in patients with systemic
sclerosis (SSc). Accurate strategies to identify its presence in early phases are essential. We …
sclerosis (SSc). Accurate strategies to identify its presence in early phases are essential. We …
Approach to interstitial lung disease associated with systemic sclerosis—A survey to pulmonologists and rheumatologists in Colombia
JL Galindo, OM García, DR Gil, LJ Cajas… - Reumatología …, 2024 - Elsevier
Introduction Interstitial lung disease is a leading cause of mortality in patients with systemic
sclerosis. Currently, there is a lack of consensus regarding screening, rescreening …
sclerosis. Currently, there is a lack of consensus regarding screening, rescreening …
New developments related to lung complications in pediatric rheumatic disease
S Rai, GS Schulert, C Towe - Current Opinion in Rheumatology, 2023 - journals.lww.com
Patients appear to have frequent lung function abnormalities while being clinically
asymptomatic, emphasizing importance for rheumatologists to refer for pulmonary function …
asymptomatic, emphasizing importance for rheumatologists to refer for pulmonary function …
Experiences of systemic sclerosis patients with home monitoring of their pulmonary function: a qualitative study
A Velauthapillai, GMM Schepers… - … Advances in Practice, 2024 - academic.oup.com
Objective To evaluate the experiences, perceived benefits and disadvantages of home
monitoring of pulmonary function in SSc patients with interstitial lung disease (ILD). Methods …
monitoring of pulmonary function in SSc patients with interstitial lung disease (ILD). Methods …